Digitisation | August 13, 2021
Labcorp, a leader in women’s heath solutions acquires Ovia Health
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21
EPS at Rs 32.19
Income declines marginally
Demand normalisation post the second wave contributed to the steady growth
It plays a pivotal role in monitoring pharmaceutical pricing
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
Subscribe To Our Newsletter & Stay Updated
